FDA Grants Abbreviated Approval for Gabapentin by Ascent Pharmaceuticals
The FDA has granted an abbreviated approval for Gabapentin under application ANDA214956 submitted by Ascent Pharmaceuticals.
Company
Pharmaceutical intelligence for Ascent Pharmaceuticals with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.